Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind cross-over study of sivopixant in refractory/unexplained chronic cough
jRCT2080223969Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sivopixant in refractory chronic cough (RCC) and chronic idiopathic cough (CIC) (2 arms), sponsored by Shionogi & Co., Ltd. Started Jul 2018; status: completed.
02
Drugs
sivopixant
03
Conditions
refractory chronic cough (RCC)chronic idiopathic cough (CIC)
Beyond the preview
Go deeper on jRCT2080223969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223969.